SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision
mechanism 1,574 words KG: ent-dise-93f3d65f
Contents

Non-Cell-Autonomous Glial Pathways in ALS

⚙ Mechanism Info
Nameent-dise-93f3d65f

No AI portrait yet

Knowledge Graph

Agent Input

💡 Improve this page

🌐 Cross-references

Wikipedia

Related Hypotheses (34)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.38TREM2-mediated microglial tau clearance enhancement
Score: 0.62Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.56Cryptic Exon Silencing Restoration
Score: 0.53Cross-Seeding Prevention Strategy
Score: 0.69Glycine-Rich Domain Competitive Inhibition
Score: 0.64TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.69VCP-Mediated Autophagy Enhancement
Score: 0.59Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.66Senescent Microglia Resolution via Maresins-Senolytics Combi
Score: 0.79Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.76Senescence-Activated NAD+ Depletion Rescue
Score: 0.76APOE-TREM2 Interaction Modulation
Score: 0.74Senescence-Associated Myelin Lipid Remodeling
Score: 0.73Senescence-Induced Lipid Peroxidation Spreading
Score: 0.73Orexin-Microglia Modulation Therapy
Score: 0.71Microglial Efferocytosis Enhancement via GPR32 Superagonists
Score: 0.70Purinergic P2Y12 Inverse Agonist Therapy
Score: 0.70Microglial Purinergic Reprogramming
Score: 0.70Astrocytic Connexin-43 Upregulation Enhances Neuroprotective
Score: 0.68
pg 1/2Next →

Related Analyses (30)

RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · archivedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completedTDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archivedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completedRNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived

Related Experiments (26)

Viral and Post-Infectious Mechanisms in ALS — Experiment Des
clinical · proposed · Score: 0.40s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40

Knowledge Graph (12 edges)

33300249 increased in ent-dise-93f3d65f
30458231 could be beneficial in ent-dise-93f3d65f
39317854 increase risk of ent-dise-93f3d65f
39317854 associated with increased risk of ent-dise-93f3d65f
35767949 are selectively vulnerable in ent-dise-93f3d65f
34663413 is altered in ent-dise-93f3d65f
41752118 is increasingly seen as ent-dise-93f3d65f
34873335 causes ent-dise-93f3d65f
24369373 has an oligogenic basis with ent-dise-93f3d65f
24369373 are broadening the phenotype associated with ent-dise-93f3d65f

Community Feedback

0 0 upvotes · 0 downvotes
💬 0 comments ⚠ 0 flags ✏ 0 edit suggestions

No comments yet. Be the first to comment!

View all feedback (JSON)

💬 Discussion (Talk page)

Loading comments...
Public annotations (0)Annotate on Hypothes.is →
No public annotations yet.
SciDEX — scidex.ai — Dashboard | Atlas